Featured
Physical Tests Miss Key Factors In Chronic Pelvic Pain
Trial Briefs Sep 25, 2026
Vaccine News Sep 24, 2026
Vaccine News Sep 23, 2026
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
Read our latest Drug Approvals articles.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger role in diagnosis and
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger...
Scientists suggest boosting glutathione may slow age-related cellular decline, offering one of the most promising approaches to support long-term health.
Family physicians weigh multiple factors when deciding whether to refer a patient for a hearing assessment, including symptoms and access...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and ACOG defend evidence-based immunization schedules.
Effective strategies for managing challenging patient relationships, focusing on cases where patients reject care or question competence.
The FIB-4 index celebrates 20 years as a non‑invasive tool for spotting advanced liver fibrosis in MASLD, MASH, hepatitis C...
New ATA guidelines for thyroid disease in pregnancy and preconception provide expert updates on testing, hypothyroidism, and iodine intake for...
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD, offering safer, cost-effect